David Villanueva, PA
Medical · Scottsdale, AZNPI 1720073273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Smith+Nephew at 31.7% of the total. Reporting peaked in 2024 at $259 and has fallen 78.6% since, to $55 in 2025. That places this record below the midpoint for medical clinicians in AZ, where the typical reported total is $625.
Across 22 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$154
- Urgo Medical North America, LLC$103
- Musculoskeletal Transplant Foundation Inc.$60
- Mimedx Group, Inc.$35
- KCI USA, Inc.$31
- OVIK Health, LLC$25
- plus $77 from 4 others
What the payments were for
- Food & beverage$485100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 7 | $154 |
| Urgo Medical North America, LLC | 2 | $103 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $60 |
| Mimedx Group, Inc. | 2 | $35 |
| KCI USA, Inc. | 2 | $31 |
| OVIK Health, LLC | 1 | $25 |
| Johnson & Johnson | 1 | $21 |
| Organogenesis Inc. | 1 | $21 |
| Solventum Corporation | 1 | $21 |
| Reprise Biomedical, Inc. | 1 | $14 |
How this compares
$485 in reported general payments places this provider in the 45th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 19 | $397 |
| Cephalexin | 31 | $274 |
| Doxycycline Hyclate | 21 | $273 |
| Metronidazole | 18 | $69 |
| Levofloxacin | 13 | $56 |
| Prednisone | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other medical in Scottsdale
- Robert CasquejoScottsdale$474K
- Darren WestScottsdale$206K
- Jamie WystrachScottsdale$79K
- Kendall JensonScottsdale$39K
- Ann Marie ChavezScottsdale$23K
- Emma ReeveScottsdale$15K
- Fiona BluntScottsdale$12K
- Francine MartynScottsdale$10K
- Victoria CarpenterScottsdale$9K
- Andrew HicksPeoria$460K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.